Get the Stockscreener App
3.61
0.00%
+0.00
After Hours:
3.61
Elevation Oncology Inc Stock (ELEV) Forecast
The Elevation Oncology Inc (ELEV) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $3.8875, representing a +7.69% increase from the current price of $3.61. The highest analyst price target is $4.8154, and the lowest is $2.9596.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ELEV Price Target
Average 2.4767
(-31.39% Downside)
Is Elevation Oncology Inc (ELEV) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 44.94 | Neutral |
| STOCH(9,6) | 37.98 | Neutral |
| STOCHRSI(14) | 77.69 | Neutral |
| MACD(12,26) | -0.1759 | Buy |
| ADX(14) | 13.73 | Neutral |
| William %R | -66.93 | Neutral |
| CCI(14) | -35.36 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.564
Buy
|
3.6195
Sell
|
| MA20 |
3.7038
Sell
|
3.7487
Sell
|
| MA50 |
4.2227
Sell
|
3.8377
Sell
|
| MA100 |
3.4344
Buy
|
3.3768
Buy
|
| MA200 |
2.0343
Buy
|
2.7443
Buy
|
Buy: 5
Sell: 5
Neutral: 0
Summary: Neutral
According to our latest analysis, ELEV could be considered a Neutral, with 17 technical analysis indicators signaling 6 Buy signals, 5 signaling Sell signals and 6 Neutral signals. This suggests that investors should exercise caution when entering new positions on ELEV, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 44.94 indicates that ELEV is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 37.98 indicates that ELEV is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 77.69 indicates that ELEV is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 13.73 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -35.36 indicates that ELEV is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term ELEV price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Elevation Oncology Inc financial reports and earnings history, Elevation Oncology Inc (ELEV) stock could reach $1.6975 by 2030, $8.1916 by 2040 and $17.59 by 2050. See the projected annual prices until 2050 of the Elevation Oncology Inc stock below:
- Elevation Oncology Inc (ELEV) is expected to reach an average price of $3.1263 in 2035, with a high prediction of $5.406 and a low estimate of $5.0643. This indicates an $-13.40% rise from the last recorded price of $3.61.
- Elevation Oncology Inc (ELEV) stock is projected to chart a bullish course in 2040, with an average price target of $8.1928, representing an $126.95% surge from its current level. The forecast ranges from a conservative $8.2227 to a sky-high $8.1916.
- Our analysts predict Elevation Oncology Inc (ELEV) to jump 261.71% by 2045, soaring from $13.22 to an average price of $13.06, potentially reaching $13.10. While $13.22 is the low estimate, the potential upside is significant.
- Elevation Oncology Inc (ELEV) stock is expected to climb by 2050, reaching an average of $17.61, a $387.93% jump from its current level. However, a wide range of estimates exists, with high and low targets of $17.59 and $17.66, respectively, highlighting the market's uncertainty.
Elevation Oncology Inc Stock (ELEV) Year by Year Forecast
Elevation Oncology Inc Stock (ELEV) Price Forecast for 2024
Our forecast for ELEV stock price in 2024 now indicates an average price target of $2.9839 with a high forecast of $5.8299 and a low forecast of $0.1379. The average prediction reflects an decrease of -17.34% from the last recorded price of $3.61.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $3.6244 | $2.9596 | $4.8154 | +0.40% |
| July, 2024 | $1.5389 | $1.374 | $3.8793 | -57.37% |
| August, 2024 | $0.8285 | $0.7985 | $1.8888 | -77.05% |
| September, 2024 | $0.7081 | $0.3434 | $1.5032 | -80.38% |
| October, 2024 | $1.5827 | $0.3079 | $1.8251 | -56.16% |
| November, 2024 | $0.3223 | $0.1823 | $2.6673 | -91.07% |
| December, 2024 | $0.4081 | $0.1379 | $0.5649 | -88.70% |
Elevation Oncology Inc Stock (ELEV) Price Forecast for 2025
Elevation Oncology Inc Stock (ELEV) is expected to reach an average price of $1.7247 in 2025, with a high prediction of $3.442 and a low estimate of $0.00732. This indicates an -52.22% fall from the last recorded price of $3.61.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $0.5535 | $0.5182 | $0.4235 | -84.67% |
| February, 2025 | $0.6239 | $0.6888 | $0.5337 | -82.72% |
| March, 2025 | $0.6543 | $0.699 | $0.7192 | -81.88% |
| April, 2025 | $0.7397 | $0.7344 | $0.6944 | -79.51% |
| May, 2025 | $0.8585 | $0.755 | $0.685 | -76.22% |
| June, 2025 | $0.8865 | $0.8876 | $0.8003 | -75.44% |
| July, 2025 | $0.8159 | $0.8536 | $0.8009 | -77.40% |
| August, 2025 | $0.7263 | $0.8012 | $0.7061 | -79.88% |
| September, 2025 | $0.6867 | $0.7364 | $0.7114 | -80.98% |
| October, 2025 | $0.8479 | $0.627 | $0.8779 | -76.51% |
| November, 2025 | $0.2675 | $0.0075 | $0.8028 | -92.59% |
| December, 2025 | $2.152 | $0.00732 | $3.442 | -40.39% |
Elevation Oncology Inc Stock (ELEV) Price Forecast for 2026
The predicted value for Elevation Oncology Inc (ELEV) in 2026 is set at an average of $2.1876. Estimates vary from a peak of $4.2369 to a trough of $0.1383, indicating an -39.40% surge from the present price of $3.61.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.2517 | $0.1383 | $4.2369 | -93.03% |
| February, 2026 | $0.0787 | $0.1587 | $0.2766 | -97.82% |
| March, 2026 | $0.3991 | $0.1537 | $0.3091 | -88.95% |
| April, 2026 | $0.8105 | $0.6142 | $0.7755 | -77.55% |
| May, 2026 | $0.8549 | $0.8296 | $0.8196 | -76.32% |
| June, 2026 | $0.8994 | $0.91 | $0.8551 | -75.09% |
| July, 2026 | $1.0107 | $1.0291 | $1.0165 | -72.00% |
| August, 2026 | $0.9338 | $0.9935 | $0.9893 | -74.13% |
| September, 2026 | $1.2734 | $0.6646 | $1.4034 | -64.72% |
| October, 2026 | $1.5031 | $0.7932 | $1.9882 | -58.36% |
| November, 2026 | $2.9827 | $1.0629 | $2.9927 | -17.38% |
| December, 2026 | $3.7272 | $2.5074 | $4.0825 | +3.25% |
Elevation Oncology Inc Stock (ELEV) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Elevation Oncology Inc (ELEV) is $2.2208, with a high forecast of $4.432 and a low forecast of $0.00963. This indicates an -38.48% decrease from the last price of $3.61.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.2369 | $2.0769 | $4.432 | -38.04% |
| February, 2027 | $1.2998 | $0.0998 | $3.34 | -63.99% |
| March, 2027 | $1.8989 | $0.00963 | $2.7649 | -47.40% |
| April, 2027 | $0.1869 | $0.0617 | $2.5686 | -94.82% |
| May, 2027 | $0.6426 | $0.6022 | $1.148 | -82.20% |
| June, 2027 | $1.4535 | $0.9492 | $1.1633 | -59.74% |
| July, 2027 | $1.6043 | $1.3546 | $1.3066 | -55.56% |
| August, 2027 | $0.695 | $0.805 | $0.6232 | -80.75% |
| September, 2027 | $2.5359 | $0.9652 | $2.0759 | -29.75% |
| October, 2027 | $2.2767 | $2.4265 | $2.3265 | -36.93% |
| November, 2027 | $2.4374 | $2.457 | $2.4174 | -32.48% |
| December, 2027 | $2.6283 | $2.5676 | $2.5783 | -27.19% |
Elevation Oncology Inc Stock (ELEV) Price Forecast for 2028
In 2028, Elevation Oncology Inc (ELEV) is projected to reach an average price of $1.3674, with a high projection of $2.6006 and a low estimate of $0.1342. This indicates an -62.12% fall from the last price of $3.61.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $2.5491 | $2.5837 | $2.5389 | -29.39% |
| February, 2028 | $2.5598 | $2.5758 | $2.4996 | -29.09% |
| March, 2028 | $2.5807 | $2.57 | $2.6006 | -28.51% |
| April, 2028 | $2.5315 | $2.6705 | $2.5816 | -29.88% |
| May, 2028 | $2.3474 | $2.5524 | $2.4718 | -34.97% |
| June, 2028 | $2.4631 | $2.4729 | $2.4528 | -31.77% |
| July, 2028 | $2.2839 | $2.3442 | $2.4033 | -36.73% |
| August, 2028 | $1.3748 | $1.4544 | $1.9441 | -61.92% |
| September, 2028 | $0.6145 | $0.7254 | $1.2552 | -82.98% |
| October, 2028 | $0.9237 | $0.1342 | $2.5839 | -74.41% |
| November, 2028 | $1.7272 | $0.2235 | $1.6972 | -52.15% |
| December, 2028 | $1.938 | $1.7675 | $1.66 | -46.32% |
Elevation Oncology Inc Stock (ELEV) Price Forecast for 2029
The 2029 price forecast for Elevation Oncology Inc Stock (ELEV) is $1.5732 on average, with a high prediction of $3.0342 and a low estimate of $0.1122. This represents an -56.42% decrease from the previous price of $3.61.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.3789 | $2.0281 | $2.3214 | -34.10% |
| February, 2029 | $2.3916 | $2.3984 | $2.3593 | -33.75% |
| March, 2029 | $2.4194 | $2.4398 | $2.4002 | -32.98% |
| April, 2029 | $2.596 | $2.4597 | $2.5371 | -28.09% |
| May, 2029 | $2.482 | $2.4895 | $2.499 | -31.25% |
| June, 2029 | $2.4158 | $2.5022 | $2.4434 | -33.08% |
| July, 2029 | $0.1535 | $0.5733 | $1.993 | -95.75% |
| August, 2029 | $0.3044 | $0.1122 | $0.5363 | -91.57% |
| September, 2029 | $1.5648 | $0.3246 | $2.665 | -56.65% |
| October, 2029 | $1.0239 | $0.9739 | $3.0342 | -71.64% |
| November, 2029 | $0.16 | $0.24 | $1.7333 | -95.57% |
| December, 2029 | $0.1611 | $1.1611 | $0.7558 | -95.54% |
Elevation Oncology Inc Stock (ELEV) Price Forecast for 2030
Elevation Oncology Inc Stock (ELEV) is expected to reach an average price of $2.5001 in 2030, with a high forecast of $4.4375 and a low forecast of $0.5627. This signifies an -30.74% decrease from the last price of $3.61.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.7375 | $0.5627 | $1.6975 | -51.87% |
| February, 2030 | $2.6386 | $2.2728 | $2.1436 | -26.91% |
| March, 2030 | $3.5597 | $2.7739 | $3.1097 | -1.39% |
| April, 2030 | $3.2108 | $3.3365 | $3.1906 | -11.06% |
| May, 2030 | $2.2872 | $3.0566 | $3.2737 | -36.64% |
| June, 2030 | $3.6283 | $2.7525 | $3.3006 | +0.51% |
| July, 2030 | $4.2847 | $3.9936 | $4.2347 | +18.69% |
| August, 2030 | $4.4058 | $4.34 | $4.2158 | +22.05% |
| September, 2030 | $4.4369 | $4.4369 | $4.3119 | +22.91% |
| October, 2030 | $4.4547 | $4.4331 | $4.4375 | +23.40% |
| November, 2030 | $4.3844 | $4.4104 | $4.3292 | +21.45% |
| December, 2030 | $4.4955 | $4.385 | $4.4055 | +24.53% |
0.77%
1.20%
Cap:
|
Volume (24h):